Collaboration offers optimal manufacturing capabilities to growing global microbiome market

合作为不断增长的全球微生物市场提供了最佳的制造能力

INDIANAPOLIS and YEERONGPILLY, Australia, March 14, 2024 /PRNewswire/ -- List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce and mutually recommend each other's microbial development and manufacturing services to prospective customers if one party discovers a project that is better suited to the other party's capability or capacity.

印第安纳波利斯和YEERONGPILLY，澳大利亚，2024年3月14日/PRNewswire/--List Biotherapeutics，Inc.（List Bio）和Sacco System Australia Pty Ltd（Sacco）今天宣布了一项铅共享协议，如果一方发现一个更适合另一方能力或能力的项目，则向潜在客户介绍并相互推荐对方的微生物开发和制造服务。

No intellectual property will be exchanged between the companies..

公司之间不交换任何知识产权。。

Sacco specializes in the development and production of probiotics, postbiotics and live bacterial therapeutics for the agri-food, food supplements and pharmaceutical industry.

Sacco专门为农业食品、食品补充剂和制药行业开发和生产益生菌、益生菌和活细菌疗法。

List Bio and its sister company, List Labs, specialize in the development and production of innovative bacterial based therapeutic products, including GMP Manufacturing of live biotherapeutic products (LBPs), and other types of microbiome-based therapeutics. Their expertise includes vast experience in purification of bacterially derived proteins and toxins for the pharmaceutical and biotechnology industries, with a catalog of over 100 reagent grade products used in medical research and vaccine development throughout the world.

List Bio及其姊妹公司List Labs专注于开发和生产创新的基于细菌的治疗产品，包括GMP生产活性生物治疗产品（LBP）和其他类型的基于微生物组的治疗剂。他们的专业知识包括在制药和生物技术行业纯化细菌衍生蛋白质和毒素方面的丰富经验，在全世界的医学研究和疫苗开发中使用了100多种试剂级产品。

List Labs boasts over 45 years of experience with bacterial derived products and a facility in Campbell, Calif. for manufacturing of early phase clinical trial material..

List Labs拥有超过45年的细菌衍生产品经验，并在加利福尼亚州坎贝尔拥有一家生产早期临床试验材料的设施。。

'This lead share agreement will help us meet the diverse global needs of microbiome therapeutics development and commercialization in a thriving market, where over 100 companies are actively developing more than 240 microbiome modulator candidates,' said List Bio President and CEO Jonathan Jo. 'We are delighted to expand List Labs and List Bio's integrated cGMP pharma grade anaerobic and spore forming microbe production capabilities to biotherapeutic developers in Europe and the Asia Pacific region through Sacco's strong client base.'.

“这项领先共享协议将帮助我们在一个蓬勃发展的市场中满足微生物组疗法开发和商业化的各种全球需求，其中100多家公司正在积极开发240多种微生物组调节剂候选产品，List Bio总裁兼首席执行官乔纳森·乔（JonathanJo）说：“我们很高兴通过Sacco强大的客户基础，将List Labs和List Bio的综合cGMP制药级厌氧和孢子形成微生物生产能力扩展到欧洲和亚太地区的生物治疗开发商。”。

Sacco Managing Director John Goebel said, 'Sacco looks forward to offering our large-scale fermentation capabilities to any List Bio or List Labs biotherapeutics clients who wish to manufacture probiotics and LBPs in large volume. We are confident that this will be the first of many future strategic alliances as the microbiome market continues to grow.'.

Sacco董事总经理约翰·戈贝尔（JohnGoebel）表示，“Sacco期待着向任何希望大量生产益生菌和LBP的List Bio或List Labs生物治疗客户提供我们的大规模发酵能力。我们相信，随着微生物市场的持续增长，这将是未来许多战略联盟中的第一个。

About List BioList Biotherapeutics, Inc. is dedicated to meeting the needs of companies seeking to rapidly and cost-effectively advance live biotherapeutic products (LBPs) through Phase 3 clinical development and commercial manufacturing. Incorporated in October 2021 under its parent company, South Korea-based Genome & Company (KOSDAQ: 314130), List Bio complements the clinical Phase 1 and 2 production capabilities of its sister company, List Labs.

About List BioList Biotherapeutics，Inc.致力于满足寻求通过第三阶段临床开发和商业制造快速且经济高效地推进活体生物治疗产品（LBP）的公司的需求。于2021年10月在其母公司韩国基因组公司（KOSDAQ:314130）下成立，List Bio补充了其姊妹公司List Labs的临床1期和2期生产能力。

Together the companies provide an end-to-end manufacturing solution for LBPs. List Bio plans to expand with additional modalities and custom manufacturing at its site in Fishers, IN, with the buildout capacity to become a top 3 global microbiome CDMO. The company's long-term plan includes a world-class 130,000 sq ft CMO facility that is cGMP compliant with FDA and EMA standards, and that is designed to meet the demands of large-scale manufacturing of aerobic and anaerobic bacterial strains.

这些公司共同为LBP提供端到端的制造解决方案。List Bio计划在年在其位于渔民的工厂扩大其他模式和定制制造，并建设成为全球前三大微生物组CDMO的能力。该公司的长期计划包括一个世界级的130000平方英尺CMO设施，该设施符合FDA和EMA标准，旨在满足大规模生产需氧和厌氧细菌菌株的需求。

For more information, please visit our website http://www.listlabs.com or contact Gary Henderson, Director of Business Development at ghenderson@listlabs.com..

有关更多信息，请访问我们的网站http://www.listlabs.com或联系Gary Henderson，业务发展总监ghenderson@listlabs.com..

About Sacco SystemSacco System is an international company with deep expertise in research and production of bacteria for food, plant, animal nutrition, nutraceutical, and pharmaceutical industries, built on more than 150 years of tradition, know-how and innovation. Sacco System's Heritage in Lactic Acid Bacteria (LAB) began in 1948, when Dr Leo Vesely founded Centro Sperimentale del Latte (CSL, integral part of Sacco System group) to improve maternal health and children's nutrition.

关于Sacco系统Sacco系统是一家国际性公司，在食品、植物、动物营养、营养保健和制药行业的细菌研究和生产方面拥有丰富的专业知识，建立在150多年的传统、专有技术和创新基础上。Sacco系统在乳酸菌（LAB）方面的传统始于1948年，当时Leo Vesely博士成立了Centro Sperimentale del Latte（CSL，Sacco系统集团的组成部分），以改善产妇健康和儿童营养。

Operating today in over 110 countries worldwide, Sacco System provides its expertise on probiotic research, development and manufacturing for human wellbeing throughout the entire microbiome landscape..

Sacco系统目前在全球110多个国家运营，在整个微生物群落领域为人类福祉提供益生菌研究、开发和制造方面的专业知识。。

With its 8 facilities, Sacco System partners with companies in the development, process validation, and finished product manufacturing of probiotics, postbiotics, next-generation bacteria (strict anaerobes) and biotherapeutics (LBPs). Sacco System's expertise lies in tailoring solutions to meet diverse industry needs.

Sacco系统拥有8个设施，与公司合作开发，工艺验证和成品制造益生菌，后生物，下一代细菌（严格厌氧菌）和生物治疗剂（LBP）。Sacco系统的专业知识在于定制解决方案以满足不同的行业需求。

Sacco Systems serves as a reliable partner, and offers comprehensive support with a range of services and solutions, including:.

Sacco Systems是一个可靠的合作伙伴，并通过一系列服务和解决方案提供全面支持，包括：。

Process development & fermentation

工艺开发与发酵

Product formulation

产品配方

In vitro and in vivo trials

体外和体内试验

Market Expansion

市场拓展

Regulatory Support

监管支持

Molecular biology & laboratory analysis

分子生物学与实验室分析

Media Contact:Connor HalversonThat's Nice LLC, on behalf of List BioTel: +1 212 366 4455Email: connor@thatsnice.com

媒体联系人：Connor HalversonThat's Nice LLC，代表List BioTel：+1 212 366 4455电子邮件：connor@thatsnice.com

SOURCE List Biotherapeutics, Inc.

来源列表Biotherapeutics，Inc。